ClinicalTrials.gg
Sign In

Esophagitis clinical trials

The registry lists 123 studies for Esophagitis across more than 10 countries. 15 are recruiting or about to start. 54 of them are mainly about Esophagitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-24. Counting its 2 narrower conditions too, such as Eosinophilic Esophagitis: 413 studies, 82 open.

Get an email when these change. Save the Esophagitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
78
Status unknown
14
Terminated
11
Recruiting
10
Not yet recruiting
3
Active, not recruiting
3

Phase

Phase 2
32
Phase 3
32
Phase 4
8
Phase 1
8
Early Phase 1
2

Where

United States
65
Korea, Republic of
12
China
11
Canada
10
United Kingdom
10
Japan
8

Who runs them

Takeda (11) · AstraZeneca (5) · Daewoong Pharmaceutical Co. LTD. (4) · HK inno.N Corporation (4) · Ellodi Pharmaceuticals, LP (4) · Pfizer (4) · University of Utah (3) · EndoGastric Solutions (3)

What is being tested here

Drugs under test in Esophagitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Alginates101
Alginic Acid101
Dupilumab101
APT-1011034
Domperidone013
Omeprazole003
Linaprazan glurate002
Cendakimab022
Lansoprazole002
Mepolizumab002

Drug classes tested here Proton pump inhibitors (PPIs) 10 · Corticosteroids 3

Coming up

3phase 3 studies under way
3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Who these studies take

Of the 10 Esophagitis studies recruiting now, 6 (60%) set no upper age limit and 4 (40%) stop at 75 or younger. 2 (20%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (10%) take healthy volunteers.

Recruiting studies that take each age, of 10
AgeWomenMen
102 (20%)2 (20%)
187 (70%)7 (70%)
309 (90%)9 (90%)
409 (90%)9 (90%)
509 (90%)9 (90%)
658 (80%)8 (80%)
756 (60%)6 (60%)
856 (60%)6 (60%)

Across all 123 studies, recruiting or not: 43% stop at 75 or younger and 21% at 65; 23% take children; 1% are for women only and 2% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Esophagitis studies take

Of 18 phase 3 interventional studies under Esophagitis, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 324 mo11–34 · 18 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 123. Browse all 123 → or search them.